Behman, J., Ahmed, N., Hashmi, S., Aljurf, M., Awan, F., Ramakishnan, P., … Abid, M. B. (2026). Female sex is associated with superior outcomes in patients treated with CD19-directed CAR T-cell therapy for large B-cell lymphoma. Haematologica. https://doi.org/10.3324/haematol.2026.300993

Behman, John, Nausheen Ahmed, Shahrukh Hashmi, Mahmoud Aljurf, Farrukh Awan, Praveen Ramakishnan, Mumtaz Yaseen, Mohamed A. Kharfan-Dabaja, Sairah Ahmed, and Muhammad Bilal Abid. “Female sex is associated with superior outcomes in patients treated with CD19-directed CAR T-cell therapy for large B-cell lymphoma.” Haematologica, July 2, 2026. https://doi.org/10.3324/haematol.2026.300993.

Behman J, Ahmed N, Hashmi S, Aljurf M, Awan F, Ramakishnan P, et al. Female sex is associated with superior outcomes in patients treated with CD19-directed CAR T-cell therapy for large B-cell lymphoma. Haematologica. 2026 Jul 2;

Behman, John, et al. “Female sex is associated with superior outcomes in patients treated with CD19-directed CAR T-cell therapy for large B-cell lymphoma.” Haematologica, July 2026. Pubmed, doi:10.3324/haematol.2026.300993.

Behman J, Ahmed N, Hashmi S, Aljurf M, Awan F, Ramakishnan P, Yaseen M, Kharfan-Dabaja MA, Ahmed S, Abid MB. Female sex is associated with superior outcomes in patients treated with CD19-directed CAR T-cell therapy for large B-cell lymphoma. Haematologica. 2026 Jul 2;